CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BGI Genomics Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BGI Genomics Co Ltd
Floor 8, Area B, BGI Space-Time Center,
Phone: +86 75536307065p:+86 75536307065 SHENZHEN, GNG  518083  China Ticker: 300676300676
Business Summary
BGI Genomics Co Ltd is a China-based company mainly engaged in genetic testing business. The Company's main business is to provide research services and comprehensive solutions for precision medicine testing for scientific research institutions, enterprises, institutions, medical institutions, social health organizations and others through multi-omics big data technology means such as genetic testing, mass spectrometry testing, and bioinformatics analysis. The Company mainly provides basic research and clinical application services for reproductive health, tumor and chronic disease prevention and control and translational medicine services, basic research and clinical application services for infection prevention and control, multi-omics big data services and synthesis business, and comprehensive solutions for precision medicine testing

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
8071 Medical laboratories
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JianWang 70
Chief Financial Officer, Deputy General Manager, Director YujueWang 46 6/18/2024 6/16/2021
Chief Operating Officer, Deputy General Manager YutaoDu 47 6/18/2024 11/14/2018
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 3,752 (As of 12/31/2023)
Outstanding Shares: 415,821,575 (As of 9/30/2024)
Shareholders: 69,673
Stock Exchange: SHE
Fax Number: +86 75536307035


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025